Courtney Lawrence: It’s Critical That as Blood Donor Eligibility Criteria Evolves, We Ensure the U.S. Blood Supply for Patients Remains Safe!
Courtney Lawrence, Divisional Chief Medical Officer at the American Red Cross, shared on LinkedIn:
”It’s critical that as blood donor eligibility criteria evolves, we sensure the U.S. blood supply for patients remains safe!
With supporting data from the experiences of other countries and ongoing studies of specific donor subpopulations, the FDA reduced the deferral period for blood donors with specific higher risk behaviors from 12 months to 3 months in 2020.
(In 2023, another huge stride was made in moving to Individualized Donor Assessment, replacing blanket deferrals based on gender and sexual orientation with evidence-based individual assessments of risks).
‘Despite reducing donor deferral periods for many infectious risk behaviors, HIV and HBV prevalence were stable, while HCV prevalence declined over 8 years.
Either slight or significant declines occurred from the pre-3M to 3M period for all agents.
Thus, changes in policy did not adversely impact the current safety of the blood supply with respect to the major infectious disease agents.’
Congratulations to the science teams from American Red Cross’s Transfusion Safety and Surveillance, Vitalant, OneBlood, New York Blood Center and the FDA on their collaborative publication in AABB Transfusion!”

Stay updated on the emerging with Hemostasis Today.
-
Jul 11, 2026, 16:07Louise St. Germain Bannon: Where Innovation Meets Collaboration at ISTH 2026
-
Jul 11, 2026, 15:22Cécile Denis: A Unique Opportunity for Emerging Hemostasis Leaders
-
Jul 11, 2026, 15:03Dino Mehic: Paris Welcomes the Global Hemostasis Community at ISTH 2026
-
Jul 11, 2026, 14:55Carsten Deppermann: An Inspiring Perspective on Scientific Discovery
-
Jul 11, 2026, 14:47Isabella Presch: Arrived in Amazing Paris For ISTH 2026
-
Jul 11, 2026, 14:12Riten Kumar: The Opening Day Experience at ISTH 2026
-
Jul 11, 2026, 13:44Mary Cushman: A Decade After the RPTH Journal Launch at ISTH 2026
-
Jul 11, 2026, 11:31Acute DVT Management and the Role of Interventions Beyond Anticoagulation: Insights From ISTH 2026
-
Jul 11, 2026, 09:48Kathleen Freson: Leaving to Paris For a Sunny ISTH 2026 Meeting